References

Global public health burden of heart failure

10.15420/cfr.2016:25:2 · 2017 · External reference

Biomarkers in heart failure

10.1056/nejmra0800239 · 2008 · External reference

Altered hemodynamics and end-organ damage in heart failure

10.1161/circulationaha.119.045409 · 2020 · External reference

ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

10.1183/13993003.00879-2022 · 2022 · External reference

Epidemiology of heart failure

10.1161/circresaha.121.318172 · 2021 · External reference

Established and emerging roles of biomarkers in heart failure

10.1161/circresaha.118.312706 · 2018 · External reference

10.1093/eurheartj/ehab368

10.1093/eurheartj/ehab368 · 2021 · External reference

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study

10.1016/s2213-2600(17)30161-3 · 2017 · External reference

Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics

10.1007/s00380-019-01548-1 · 2020 · External reference

Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension

2022 · External reference

Relation of lymphangiogenic factor vascular endothelial growth factor-d to elevated pulmonary artery wedge pressure

10.1016/j.amjcard.2019.05.056 · 2019 · External reference

Vascular endothelial growth factor D, pulmonary congestion, and incidence of heart failure

10.1016/j.jacc.2017.11.058 · 2018 · External reference

10.1093/eurheartj/ehs104

10.1093/eurheartj/ehs104 · 2012 · External reference

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

10.1016/j.healun.2010.05.034 · 2010 · External reference

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

10.1016/j.healun.2005.03.019 · 2005 · External reference

10.1093/eurheartj/ehv317

10.1093/eurheartj/ehv317 · 2016 · External reference

The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population

2014 · External reference

Repeated measures correlation

10.3389/fpsyg.2017.00456 · 2017 · External reference

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update

10.1016/j.healun.2015.10.023 · 2016 · External reference

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

10.1016/j.healun.2022.10.015 · 2023 · External reference

International Society of Heart and Lung Transplantation position statement on the role of right heart catheterization in the management of heart transplant recipients

10.1016/j.healun.2018.12.009 · 2019 · External reference

Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology

10.1002/ejhf.2664 · 2022 · External reference

Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis

10.1016/j.ijcard.2014.08.072 · 2014 · External reference

Pulmonary capillary wedge pressure augments right ventricular pulsatile loading

10.1161/circulationaha.111.051540 · 2012 · External reference

Effect of diuresis on the performance of the failing left ventricle in man

10.1016/0002-9343(81)90755-5 · 1981 · External reference

Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide

10.1002/clc.4960100203 · 1987 · External reference

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

10.1073/pnas.95.2.548 · 1998 · External reference

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

10.1161/01.res.0000073584.46059.e3 · 2003 · External reference

Vascular endothelial growth factor-D mediates fibrogenic response in myofibroblasts

10.1007/s11010-015-2646-1 · 2016 · External reference

Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance

10.3109/08977194.2012.704917 · 2012 · External reference

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation

10.1172/jci200522037 · 2005 · External reference

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management

10.1164/rccm.201607-1384st · 2016 · External reference

Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke

10.1136/heartjnl-2018-313684 · 2019 · External reference

Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation

10.1183/23120541.00037-2019 · 2019 · External reference

Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension

10.1080/03009742.2017.1378714 · 2018 · External reference

Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure

2013 · External reference

Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction

10.1016/j.jchf.2015.01.013 · 2015 · External reference

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

10.1093/cvr/cvad039 · 2023 · External reference

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

10.1093/jb/mvs136 · 2012 · External reference

The vascular marker soluble Fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure

10.1016/j.jacc.2011.03.032 · 2011 · External reference

New potential diagnostic biomarkers for pulmonary hypertension

10.1183/13993003.00187-2015 · 2015 · External reference

Complications of cardiac transplantation

10.1007/s11886-018-1018-3 · 2018 · External reference

Elevated soluble Fms-like tyrosine kinase-1 and placental-like growth factor levels are associated with development and mortality risk in heart failure

10.1161/circheartfailure.115.002115 · 2016 · External reference

Association of soluble Flt-1 with heart failure and cardiac morphology: the MESA angiogenesis study

10.1016/j.healun.2022.01.003 · 2022 · External reference

Treatment with recombinant placental growth factor (PLGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction

10.1253/circj.cj-08-1067 · 2009 · External reference

Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction

10.1161/circulationaha.117.031608 · 2018 · External reference

Pathophysiologic processes and novel biomarkers associated with congestion in heart failure

2022 · External reference

Left ventricular heart failure and pulmonary hypertension

10.1093/eurheartj/ehv512 · 2015 · External reference

Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction

10.1172/jci99659 · 2018 · External reference

Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling

10.1172/jci58832 · 2012 · External reference